FDA approves wearable device for opioid withdrawal symptom treatment device

DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal. The device, called Drug Relief, is now available to providers in the US, and is distributed in the EU by the DyAnsys’ European branch.

from MobiHealthNews https://ift.tt/2yfjZoQ